Terms: = Prostate cancer AND MSN, P26038, 4478, ENSG00000147065
21 results:
1. Impact of forced diuresis at two different time points on pelvic imaging in prostatic carcinoma with 68 Ga-PSMA PET/CT.
Raju S; Sharma A; Kumar S; Seth A; Sharma A; Pandey AK; Kumar R
Nucl Med Commun; 2023 Dec; 44(12):1135-1143. PubMed ID: 37799105
[TBL] [Abstract] [Full Text] [Related]
2. Constituents of
Malarz J; Michalska K; Galanty A; Kiss AK; Stojakowska A
Molecules; 2023 Jan; 28(2):. PubMed ID: 36677535
[TBL] [Abstract] [Full Text] [Related]
3. Egg-yolk core-shell mesoporous silica nanoparticles for high doxorubicin loading and delivery to prostate cancer cells.
Tiburcius S; Krishnan K; Jose L; Patel V; Ghosh A; Sathish CI; Weidenhofer J; Yang JH; Verrills NM; Karakoti A; Vinu A
Nanoscale; 2022 May; 14(18):6830-6845. PubMed ID: 35441642
[TBL] [Abstract] [Full Text] [Related]
4. Efficient Photodynamic Therapy of prostate cancer Cells through an Improved Targeting of the Cation-Independent Mannose 6-Phosphate Receptor.
Bouffard E; Mauriello Jimenez C; El Cheikh K; Maynadier M; Basile I; Raehm L; Nguyen C; Gary-Bobo M; Garcia M; Durand JO; Morère A
Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31181759
[TBL] [Abstract] [Full Text] [Related]
5. Facile development, characterization, and evaluation of novel bicalutamide loaded pH-sensitive mesoporous silica nanoparticles for enhanced prostate cancer therapy.
Saroj S; Rajput SJ
Drug Dev Ind Pharm; 2019 Apr; 45(4):532-547. PubMed ID: 30582382
[TBL] [Abstract] [Full Text] [Related]
6. cancer cell membrane-cloaked mesoporous silica nanoparticles with a pH-sensitive gatekeeper for cancer treatment.
Liu CM; Chen GB; Chen HH; Zhang JB; Li HZ; Sheng MX; Weng WB; Guo SM
Colloids Surf B Biointerfaces; 2019 Mar; 175():477-486. PubMed ID: 30572156
[TBL] [Abstract] [Full Text] [Related]
7. Kallikrein-related peptidases 4, 5, 6 and 7 regulate tumour-associated factors in serous ovarian cancer.
Wang P; Magdolen V; Seidl C; Dorn J; Drecoll E; Kotzsch M; Yang F; Schmitt M; Schilling O; Rockstroh A; Clements JA; Loessner D
Br J Cancer; 2018 Oct; 119(7):1-9. PubMed ID: 30287916
[TBL] [Abstract] [Full Text] [Related]
8.
Farolfi A; Ceci F; Castellucci P; Graziani T; Siepe G; Lambertini A; Schiavina R; Lodi F; Morganti AG; Fanti S
Eur J Nucl Med Mol Imaging; 2019 Jan; 46(1):11-19. PubMed ID: 29905907
[TBL] [Abstract] [Full Text] [Related]
9. Improved sandwich-format electrochemical immunosensor based on "smart" SiO
Zhang D; Li W; Ma Z
Biosens Bioelectron; 2018 Jun; 109():171-176. PubMed ID: 29554477
[TBL] [Abstract] [Full Text] [Related]
10. Tailor-made pH-sensitive polyacrylic acid functionalized mesoporous silica nanoparticles for efficient and controlled delivery of anti-cancer drug Etoposide.
Saroj S; Rajput SJ
Drug Dev Ind Pharm; 2018 Jul; 44(7):1198-1211. PubMed ID: 29412022
[TBL] [Abstract] [Full Text] [Related]
11. Data-Independent Mass Spectrometry Approach for Screening and Identification of DNA Adducts.
Guo J; Villalta PW; Turesky RJ
Anal Chem; 2017 Nov; 89(21):11728-11736. PubMed ID: 28977750
[TBL] [Abstract] [Full Text] [Related]
12. A Comprehensive, Open-source Platform for Mass Spectrometry-based Glycoproteomics Data Analysis.
Liu G; Cheng K; Lo CY; Li J; Qu J; Neelamegham S
Mol Cell Proteomics; 2017 Nov; 16(11):2032-2047. PubMed ID: 28887379
[TBL] [Abstract] [Full Text] [Related]
13. Quantitative and correlative biodistribution analysis of
Kramer L; Winter G; Baur B; Kuntz AJ; Kull T; Solbach C; Beer AJ; Lindén M
Nanoscale; 2017 Jul; 9(27):9743-9753. PubMed ID: 28678239
[TBL] [Abstract] [Full Text] [Related]
14. Comparison of external beam radiotherapy versus permanent seed brachytherapy as monotherapy for intermediate-risk prostate cancer - a single center Canadian experience.
Delouya G; Lambert C; Bahary JP; Beauchemin MC; Barkati M; Ménard C; Taussky D
Can J Urol; 2017 Jun; 24(3):8822-8826. PubMed ID: 28646937
[TBL] [Abstract] [Full Text] [Related]
15. Reduced graphene oxide-functionalized FeOOH for signal-on photoelectrochemical sensing of prostate-specific antigen with bioresponsive controlled release system.
Zhou Q; Lin Y; Shu J; Zhang K; Yu Z; Tang D
Biosens Bioelectron; 2017 Dec; 98():15-21. PubMed ID: 28646718
[TBL] [Abstract] [Full Text] [Related]
16. Asymptotic dynamics of some t-periodic one-dimensional model with application to prostate cancer immunotherapy.
Foryś U; Bodnar M; Kogan Y
J Math Biol; 2016 Oct; 73(4):867-83. PubMed ID: 26897354
[TBL] [Abstract] [Full Text] [Related]
17. A comparative analysis of prostate cancer pre-treatment characteristics stratified by age.
Shah N; Ioffe V; Kapur A
Can J Urol; 2014 Apr; 21(2):7213-6. PubMed ID: 24775574
[TBL] [Abstract] [Full Text] [Related]
18. Comparative safety analysis of surgical smoke from transurethral resection of the bladder tumors and transurethral resection of the prostate.
Zhao C; Kim MK; Kim HJ; Lee SK; Chung YJ; Park JK
Urology; 2013 Sep; 82(3):744.e9-14. PubMed ID: 23890662
[TBL] [Abstract] [Full Text] [Related]
19. Can people find patient decision aids on the Internet?
Morris D; Drake E; Saarimaki A; Bennett C; O'Connor A
Patient Educ Couns; 2008 Dec; 73(3):557-60. PubMed ID: 18789628
[TBL] [Abstract] [Full Text] [Related]
20. Obesity and positive surgical margins by anatomic location after radical prostatectomy: results from the Shared Equal Access Regional cancer Hospital database.
; Jayachandran J; Aronson WJ; Terris MK; Presti JC; Amling CL; Kane CJ; Freedland SJ
BJU Int; 2008 Sep; 102(8):964-8. PubMed ID: 18691176
[TBL] [Abstract] [Full Text] [Related]
[Next]
